Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acamprosate in Bipolar Alcoholics
NCT00466661Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Apr 2007
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in alcohol dependence comparing Acamprosate with Placebo (2 arms). Primary endpoint: Time to First Drink at 8 weeks. Started Apr 2007; status: completed.
02
Drugs
acamprosate
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00466661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466661.